1. INTRODUCTION:

Amaryllis belladonna, commonly known as the Naked Ladies plant, March Lily, or Jersey Lily, is a bulbous perennial plant belonging to the family Amaryllidaceae. It is native to South Africa but has been widely introduced to various regions with Mediterranean climates, including California, Australia, and parts of Europe¹.

The plant is renowned for its striking, trumpet-shaped pink flowers that emerge in late summer, often without accompanying leaves, hence the nickname "naked ladies" ².

This plant thrives in well-drained soils and warm climates, which makes it a favored ornamental species in gardens and landscapes due to its striking floral display and adaptability to diverse environmental conditions ³.

Traditionally, Amaryllis belladonna has been used in folk medicine for its purported medicinal properties. In South African traditional practices, it is believed to possess analgesic and anti-inflammatory effects and has been used to treat ailments such as pain, wounds, and fevers⁴.

Modern pharmacological studies have identified bioactive alkaloids in Amaryllis belladonna—notably lycorine, galantamine, and crinine—known for their diverse biological activities⁵. Galantamine, for instance, is a well-recognized acetylcholinesterase inhibitor and is used in the management of Alzheimer’s disease⁶. Other compounds, such as lycorine, exhibit anticancer and antimicrobial properties, making the plant a valuable resource for drug discovery ⁷.

This review aims to provide a comprehensive overview of the phytochemical constituents and therapeutic potential of Amaryllis belladonna. It focuses on highlighting the plant's phytochemical diversity, with an emphasis on its alkaloids, flavonoids, and other secondary metabolites. The review explores its wide range of pharmacological activities, including anticancer, antimicrobial, neuroprotective, and anti-inflammatory effects. Additionally, it addresses safety concerns and toxicological profiles to evaluate the plant's potential for safe medicinal applications. Furthermore, the review identifies gaps in current research and proposes future directions to advance the understanding and utilization of Amaryllis belladonna in therapeutic contexts.

2. Botanical and Morphological Description:

Taxonomy and Classification:

Amaryllis belladonna is a member of the family Amaryllidaceae, which includes approximately 85 genera and over 1,200 species of flowering plants, many valued for their ornamental and medicinal properties⁸. Taxonomically, it is classified under the kingdom Plantae, order Asparagales, genus Amaryllis, and species A. belladonna. The genus Amaryllis is monotypic, containing only A. belladonna, and is distinguished from other members of the Amaryllidaceae family by its unique flowering pattern, bulb morphology, and growth cycle.⁹

Physical Characteristics:

Amaryllis belladonna is a perennial herbaceous plant with unique morphological features:

· Flowers: The flowers are trumpet-shaped and borne on a leafless stalk (scape) that can reach up to 60 cm in height. Typically, 2–12 flowers are arranged in an umbel at the tip of the scape, displaying shades of pink to purplish hues, though white variants are occasionally observed ¹⁰. Each flower measures about 6–10 cm in diameter and emits a light, pleasant fragrance.

· Leaves: The leaves are strap-shaped, glossy, and bright green, growing in a basal rosette. They appear after the flowering period, creating a dichotomy between foliage and floral phases¹¹.

· Bulbs: The bulb is large, ovoid, and tunicated, measuring 5–10 cm in diameter. It serves as a storage organ, enabling the plant to endure prolonged periods of dormancy and drought¹².

· Roots: The root system consists of fibrous roots emerging from the base of the bulb, anchoring the plant and facilitating nutrient absorption¹³.

Habitat and Ecological Preferences:

Amaryllis belladonna is native to the Cape Province of South Africa, where it thrives in Mediterranean climates characterized by wet winters and dry summers. It has since been naturalized in regions with similar conditions, such as parts of California, Australia, and the Mediterranean basin ¹⁴.

· Soil Requirements: Prefers well-drained sandy or loamy soils with a slightly acidic to neutral pH.

· Climate: Requires full sun to partial shade and thrives in temperatures ranging from 10–30°C. It is drought-tolerant but sensitive to frost¹⁵.

· Ecological Role: The plant's flowers are primarily pollinated by insects such as bees and moths. Its bulbs can remain dormant for extended periods, making it an adaptable species for arid environments¹⁶.

3. Ethnobotanical Significance:

Amaryllis belladonna has been an integral part of traditional medicine, particularly in South Africa, where it is native. Indigenous communities have used various parts of the plant for therapeutic purposes due to its wide range of pharmacological activities ¹⁷.

· South African Traditional Medicine: The bulb extracts are commonly used as a remedy for fevers, skin infections, and inflammation. Decoctions of the bulb are applied topically to treat wounds and ulcers. Some tribes have used Amaryllis belladonna as a treatment for digestive disorders and pain relief.

· European Cultures: In regions where the plant was introduced, such as the Mediterranean, it became a part of folk medicine for treating colds and respiratory ailments. The fragrant flowers were also used in aromatherapy for relaxation and stress relief.

· Asian and Australian Use: Although less documented, the plant's ornamental and symbolic significance in certain Asian and Australian cultures hints at its historical value, including possible use in ceremonies and traditional remedies¹⁸.

Historical Applications in Folk Medicine:

The historical use of Amaryllis belladonna in folk medicine aligns with its phytochemical properties, particularly its alkaloid content:

· Pain Management: The plant's bulb contains bioactive compounds believed to act as analgesics, historically used for treating headaches, muscle pain, and rheumatism.

· Skin and Wound Healing: Crushed bulb preparations were applied directly to wounds, burns, and skin conditions, leveraging their antimicrobial and anti-inflammatory effects.

· Anti-pyretic: Decoctions made from the bulb were ingested to reduce fevers, demonstrating early recognition of the plant's pharmacological activity¹⁹.

· Spiritual and Ritualistic Use: In addition to medicinal purposes, Amaryllis belladonna held a symbolic role in rituals. The plant's sudden flowering without leaves was often viewed as a sign of spiritual significance, symbolizing renewal and rebirth in certain African and Mediterranean traditions ²⁰.

4. Phytochemical Composition:

Amaryllis belladonna is rich in a variety of phytochemicals, including alkaloids, flavonoids, saponins, and terpenoids, which contribute to its diverse pharmacological properties. These bioactive compounds are responsible for the plant's significant therapeutic activities, such as anticancer, neuroprotective, anti-inflammatory, and antimicrobial effects. These attributes highlight the potential of Amaryllis belladonna as a valuable medicinal plant.

Table 1 summarizes the key phytochemical constituents of Amaryllis belladonna, along with their respective pharmacological activities.

Alkaloids: The most notable class of phytochemicals in Amaryllis belladonna is alkaloids, which contribute significantly to its pharmacological properties:

· Lycorine: Lycorine is a major bioactive alkaloid found in Amaryllis belladonna. It has demonstrated a wide range of biological activities, including antitumor, antiviral, and anti-inflammatory effects. Studies suggest that lycorine exerts its antitumor effects by inhibiting protein synthesis and promoting apoptosis in cancer cells.

· Galantamine: Galantamine, another prominent alkaloid, is widely recognized for its role in treating Alzheimer’s disease by inhibiting acetylcholinesterase, thus enhancing cholinergic neurotransmission. It is derived from the bulbs and is among the most pharmacologically significant alkaloids in the plant.

· Other Alkaloids: Additional alkaloids, such as haemanthamine, crinine, and hippeastrine, are present and exhibit antimicrobial and cytotoxic activities ²¹.

Table 1: Phytochemical Constituents of Amaryllis belladonna

Class of Compounds	Major Compounds	Pharmacological Activity	Ref.
Alkaloids	Lycorine, Galantamine, Crinine, Haemanthamine, Hippeastrine	Anticancer, antimicrobial, neuroprotective, anti-inflammatory, analgesic	21
Flavonoids	Quercetin, Kaempferol	Antioxidant, anti-inflammatory, neuroprotective, antimicrobial	22
Saponins	-	Immune-boosting, hemolytic, anti-inflammatory	23
Terpenoids	Monoterpenes, Sesquiterpenes	Antimicrobial, anti-inflammatory	23

Flavonoids:

Amaryllis belladonna contains flavonoids, which are potent antioxidants that play a crucial role in protecting cells from oxidative stress and free radical damage. These compounds are renowned for their anti-inflammatory and neuroprotective properties, making them valuable in managing conditions such as neurodegenerative diseases. Additionally, the flavonoids in Amaryllis belladonna contribute to its antimicrobial activity, particularly against Gram-positive bacteria and fungi, further enhancing its therapeutic potential²².

Saponins and Terpenoids:

· Saponins: Saponins in Amaryllis belladonna are known for their surface-active properties and their ability to boost immune responses. They also exhibit hemolytic and anti-inflammatory effects, enhancing the therapeutic potential of the plant.

· Terpenoids: Terpenoids, including monoterpenes and sesquiterpenes, contribute to the plant’s fragrance and display antimicrobial and anti-inflammatory activities ²³.

Analytical Techniques Used for Compound Identification:

The identification and characterization of phytochemicals in Amaryllis belladonna rely on advanced analytical techniques:

· Gas Chromatography-Mass Spectrometry (GC-MS): GC-MS is extensively used to identify volatile and semi-volatile compounds, including terpenoids and alkaloids. It is particularly effective for separating and analyzing complex mixtures.

· Liquid Chromatography-Mass Spectrometry (LC-MS): LC-MS is a powerful tool for identifying non-volatile and thermally labile compounds, such as flavonoids and saponins. It combines the high separation efficiency of liquid chromatography with the sensitivity and specificity of mass spectrometry.

· High-Performance Liquid Chromatography (HPLC): HPLC is frequently employed to quantify bioactive compounds like lycorine and galantamine in plant extracts. Its versatility and accuracy make it indispensable for phytochemical analysis.

· Nuclear Magnetic Resonance (NMR) Spectroscopy: NMR is used for structural elucidation of isolated compounds, providing detailed information about the molecular structure of alkaloids and flavonoids²⁴.

5. Pharmacological Activities:

Amaryllis belladonna exhibits diverse pharmacological activities, primarily attributed to its rich phytochemical composition, including alkaloids and flavonoids. These bioactive compounds demonstrate anticancer, antimicrobial, anti-inflammatory, and neuroprotective effects, along with antioxidant, antimalarial, and hepatoprotective properties. The plant's therapeutic potential highlights its promise for developing novel treatments for various diseases. Figure 1 & Table 2 summarises the pharmacological activities of Amaryllis belladonna.

Figure 1: Pharmacological Activities of Amaryllis belladonna

Anticancer Properties:

The alkaloids in Amaryllis belladonna, particularly lycorine, exhibit potent anticancer properties. Lycorine induces apoptosis by activating the intrinsic mitochondrial pathway and upregulating pro-apoptotic proteins like Bax while suppressing anti-apoptotic proteins such as Bcl-2. Lycorine also inhibits cell proliferation by disrupting protein synthesis and arresting the cell cycle at the G1 or G2/M phase in various cancer cell lines²⁵.

In breast cancer, lycorine has been shown to inhibit tumor growth and metastasis by targeting signaling pathways such as PI3K/Akt and Wnt/β-catenin. Studies have reported significant cytotoxic effects of Amaryllis belladonna extracts on leukemia and lung cancer cell lines, with IC50 values in the low micromolar range ²⁶. Crinine and haemanthamine, other alkaloids from the plant, also exhibit cytotoxicity against colon and ovarian cancer cells ²⁷.

Antimicrobial Effects:

Alkaloids and flavonoids in Amaryllis belladonna exhibit broad-spectrum antimicrobial activity. Lycorine has shown inhibitory effects against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Extracts have demonstrated antifungal activity against Candida albicans and Aspergillus niger, attributed to the disruption of fungal cell membranes. Lycorine also possesses antiviral activity, particularly against RNA viruses like SARS-CoV and Zika virus, by inhibiting viral replication. The plant’s antimicrobial properties make it a potential candidate for developing new antibiotics and antifungal drugs, addressing growing resistance to conventional therapies ²⁸.

Anti-inflammatory and Analgesic Effects:

Flavonoids and alkaloids in Amaryllis belladonna inhibit pro-inflammatory cytokines such as TNF-α and IL-6, reducing inflammation in models of arthritis and colitis. The plant’s extracts are effective in attenuating pain responses by modulating cyclooxygenase (COX) pathways, specifically COX-2 inhibition. Lycorine and galantamine have been identified as key compounds responsible for the anti-inflammatory effects, showing efficacy in preclinical pain models ²⁹.

Table 2: Pharmacological Activities of Amaryllis belladonna

Pharmacological Activity	Key Compounds Involved	Effect	Ref.
Anticancer	Lycorine, Crinine, Haemanthamine	Induces apoptosis, inhibits cell proliferation, cytotoxic to cancer cells	25, 26, 27
Antimicrobial	Lycorine, Flavonoids	Broad-spectrum activity against bacteria, fungi, and viruses	28
Anti-inflammatory and Analgesic	Lycorine, Galantamine	Reduces inflammation, modulates COX pathways, relieves pain	29
Neuroprotective	Galantamine	Enhances cholinergic transmission, protects neurons in Alzheimer's	30
Antioxidant	Flavonoids, Polyphenols	Reduces oxidative stress, protects against tissue damage	31
Antimalarial	Lycorine	Inhibits Plasmodium falciparum growth	32
Hepatoprotective	Extracts of A. belladonna	Protects liver cells from toxin-induced damage	33

Neuroprotective Potential:

Galantamine, an acetylcholinesterase inhibitor, enhances cholinergic transmission, making it effective in the management of Alzheimer’s disease. Studies have demonstrated galantamine’s ability to prevent neuronal cell death, reduce oxidative stress, and improve cognitive function in animal models of dementia³⁰.

Antioxidant Effects:

Flavonoids and polyphenols in Amaryllis belladonna neutralize reactive oxygen species (ROS), reducing oxidative stress and associated tissue damage. The plant’s antioxidant activity has been linked to its protective effects in conditions such as diabetes and cardiovascular diseases ³¹.

Antimalarial Effects:

Lycorine has demonstrated antimalarial properties by inhibiting the growth of Plasmodium falciparum, making it a promising candidate for malaria treatment³².

Hepatoprotective Effects:

Extracts of Amaryllis belladonna protect liver cells from damage induced by toxins like carbon tetrachloride and acetaminophen, likely through its antioxidant and anti-inflammatory mechanisms³³.

6. Toxicological Profile and Safety Concerns:

Amaryllis belladonna contains lycorine, an alkaloid with both therapeutic potential and toxicity, affecting cellular function, the CNS, and the GI system. Table 3 highlights its safety concerns.

Amaryllis belladonna contains several bioactive alkaloids, with lycorine being one of the most studied and concerning in terms of toxicity. Lycorine is a potent alkaloid that has shown promising pharmacological properties but also exhibits toxic effects when consumed in high doses. Lycorine belongs to the group of Amaryllidaceae alkaloids and has been classified as a "toxic alkaloid" due to its effects on cellular function and its impact on the central nervous system (CNS) and gastrointestinal system.

Other alkaloids found in Amaryllis belladonna, such as haemanthamine, are also associated with mild toxicity, though their effects are less pronounced compared to lycorine. Lycorine exerts its toxicity through inhibition of protein synthesis, which can lead to cell death, particularly in tissues with high metabolic demands³⁴. Furthermore, it has been shown to inhibit certain enzymes involved in cellular energy metabolism, further contributing to its toxic profile.

Toxic Doses and Effects in Humans and Animals:

Humans: The toxic dose of lycorine in humans has not been fully established, but its ingestion can lead to severe poisoning. Symptoms of toxicity include nausea, vomiting, diarrhea, abdominal pain, and excessive salivation. In severe cases, poisoning may lead to hypotension, respiratory distress, and convulsions. Deaths have been reported in cases of ingestion of large quantities of the bulbs or extracts, especially in children who may be attracted to the plant due to its appealing flowers ³⁵.

Animals: In animal models, lycorine has demonstrated a toxic dose that can vary depending on the species. In rats, a dose of 20 mg/kg of lycorine has been shown to cause significant toxicity, including signs of CNS depression, hypothermia, and respiratory distress. The lethal dose for animals has been estimated to be around 50-100 mg/kg, depending on the route of administration. In addition to lycorine, the bulbs and other parts of the plant may contain other alkaloids, leading to synergistic toxic effects in some cases³⁶.

Specific Toxicological Effects:

· Gastrointestinal Toxicity: Ingestion of plant parts or extracts can irritate the gastrointestinal tract, causing nausea, vomiting, and diarrhea, which are common symptoms of alkaloid poisoning.

· CNS Toxicity: Lycorine is known to cross the blood-brain barrier and affect CNS function, leading to convulsions, lethargy, and even coma in high doses.

· Hepatotoxicity and Renal Toxicity: There is some evidence suggesting that lycorine and other compounds in Amaryllis belladonna can exert toxic effects on the liver and kidneys, potentially leading to organ damage³⁷.

Recommendations for Safe Medicinal Use:

Given the toxicity concerns, it is essential to consider several safety measures for the use of Amaryllis belladonna in medicinal applications.

· Dosage and Standardization: The alkaloid content in Amaryllis belladonna can vary significantly depending on the source and part of the plant used. Medicinal preparations should be standardized to ensure consistent and safe dosages. The use of purified alkaloids, such as galantamine, should be preferred over crude extracts to minimize the risk of toxicity³⁸.

· Professional Supervision: Due to the narrow therapeutic index of lycorine and other alkaloids, medicinal use of Amaryllis belladonna should be conducted under professional supervision. This is particularly important for individuals with preexisting medical conditions, such as liver or kidney dysfunction, as these may be exacerbated by the toxic effects of the plant³⁹.

· Contraindications and Caution: Amaryllis belladonna should be avoided in pregnant and breastfeeding women, as its alkaloids could potentially harm fetal development and lactation⁴⁰. Additionally, the use of this plant in children should be strictly controlled to prevent accidental poisoning.

· Alternative Preparations: When possible, other safer plant-based remedies with similar therapeutic benefits should be considered, particularly for long-term use or for individuals with a history of sensitivity to alkaloids⁴¹.

7. Challenges and Future Directions:

The future of Amaryllis belladonna research faces challenges such as gaps in pharmacological knowledge, the need for clinical trials, and sustainable cultivation practices. Addressing these issues is crucial for its safe and effective use.

Knowledge Gaps in Pharmacological Research:

Despite the promising pharmacological properties of Amaryllis belladonna, there remain significant knowledge gaps that hinder its full therapeutic potential. One of the major challenges is the incomplete understanding of the pharmacological mechanisms underlying its bioactive compounds, such as lycorine and galantamine. While these alkaloids have demonstrated activity in vitro, their precise molecular targets and modes of action are not fully elucidated. There is also a lack of robust studies on the synergistic effects of multiple compounds present in the plant and their interaction with other drugs. Furthermore, many studies rely on animal models, and translating these findings to human clinical outcomes remains a complex challenge.

Another limitation is the variability in the chemical composition of Amaryllis belladonna, depending on factors such as geographic location, seasonal variations, and cultivation methods. Standardization of the plant's bioactive content is essential for ensuring consistent therapeutic effects. Further research is needed to develop accurate methods for isolating and quantifying individual compounds in different parts of the plant, which will contribute to the standardization and clinical use of Amaryllis belladonna⁴².

Need for Clinical Trials and Pharmacokinetics Studies:

The pharmacological potential of Amaryllis belladonna has primarily been explored through in vitro studies and preclinical animal models. However, there is a crucial need for well-designed human clinical trials to validate the efficacy, safety, and therapeutic potential of its bioactive compounds. Existing studies on human subjects are minimal and mostly limited to case reports or small-scale observational studies. Thus, large-scale randomized controlled trials (RCTs) are essential to evaluate the clinical effectiveness of Amaryllis belladonna in treating conditions such as Alzheimer's disease, cancer, and inflammation.

Pharmacokinetic studies are also required to understand the absorption, distribution, metabolism, and excretion (ADME) profiles of the key compounds found in Amaryllis belladonna. These studies would shed light on the bioavailability of active alkaloids like galantamine and lycorine, their half-life in the body, and the potential for drug interactions. Furthermore, information on dosage optimization and therapeutic windows would be invaluable in determining the safe use of this plant in clinical settings⁴³. Such pharmacokinetic studies would be instrumental in translating preclinical findings into practical therapeutic applications.

Sustainable Cultivation and Conservation Strategies:

While Amaryllis belladonna holds great promise for medicinal use, the large-scale demand for its bioactive compounds raises concerns about its cultivation and conservation. Overharvesting from wild populations, combined with habitat loss due to urbanization and climate change, threatens the sustainability of this plant species. Consequently, there is a pressing need to establish sustainable cultivation practices to ensure a continuous supply of the plant without compromising its natural populations.

Conservation strategies should focus on promoting the cultivation of Amaryllis belladonna in controlled environments. These strategies should also emphasize the protection of its natural habitats, preventing over-exploitation, and supporting biodiversity conservation initiatives. Furthermore, cultivation methods should be optimized to ensure high yields of bioactive compounds while minimizing the environmental impact. Integrating biotechnology and tissue culture techniques could also prove beneficial in producing high-quality plant material and improving the yield of alkaloids, especially in the face of changing environmental conditions⁴⁴.

Additionally, addressing the environmental concerns related to the use of chemical fertilizers and pesticides in large-scale cultivation will be crucial to maintaining both the quality of the plant's bioactive compounds and its ecological footprint. Therefore, organic farming methods and sustainable agricultural practices need to be explored and adopted⁴⁵.

8. CONCLUSION:

Amaryllis belladonna is a remarkable plant with an abundance of bioactive compounds, notably alkaloids like lycorine and galantamine, which exhibit a wide range of pharmacological activities. Its phytochemical richness has demonstrated therapeutic potential against cancer, microbial infections, inflammation, and neurodegenerative diseases, making it a promising candidate for drug discovery and development. In addition, its antioxidant and hepatoprotective properties further highlight its versatility as a medicinal plant. However, the presence of toxic alkaloids, such as lycorine, underscores the importance of balancing its benefits and risks. Improper dosing or inadequate processing could lead to adverse effects, emphasizing the need for proper standardization, clear dosing guidelines, and comprehensive safety evaluations. Regulatory frameworks and quality control measures are crucial to facilitating its safe integration into modern medicine.

Future research should adopt an interdisciplinary approach, combining pharmacological, toxicological, and clinical studies to explore the plant’s full potential. Clinical trials, pharmacokinetics, and pharmacodynamics studies are particularly vital to translate preclinical findings into therapeutic applications. Additionally, sustainable cultivation and conservation strategies must be prioritized to ensure a steady supply of plant material while preserving its natural populations. These efforts will contribute to unlocking the medicinal potential of Amaryllis belladonna and addressing global health challenges effectively.

9. REFERENCES:

1. Stearn WT. The Amaryllis Family: A Taxonomic Revision. London: Royal Botanic Gardens; 1998.

2. Snijman DA. A Revision of the Genus Amaryllis. Botany Journal of South Africa. 2002;37(4):315-26.

3. Anderson JG. Horticultural Aspects of Amaryllis belladonna. Horticultural Review. 2015;42(3):127-35.

4. Van Wyk BE, Gericke N. People's Plants: A Guide to Useful Plants of Southern Africa. Pretoria: Briza Publications; 2000.

5. Bastida J, Berkov S, Torras-Claveria L, Codina C. The Alkaloids of the Amaryllidaceae Family. Phytochemistry Reviews. 2006;5(1):1-19.

6. Heinrich M, Teoh HL. Galanthamine from snowdrop—the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. J Ethnopharmacol. 2004;92(2-3):147-62.

7. Elgorashi EE, Van Staden J. Pharmacological Properties of Amaryllidaceae Alkaloids: A Review. Planta Med. 2004;70(10):847-52.

8. Meerow AW, Snijman DA. Phylogeny of the Amaryllidaceae: Molecules and Morphology. Annals of Botany. 1998;81(5):527-37.

9. Duncan G. The Amaryllis Family: A Comprehensive Guide. Cape Town: National Botanical Institute; 2002.

10. Snijman DA. A Systematic Revision of Amaryllis belladonna. Botanical Journal of South Africa. 2004;40(1):45-56.

11. Manning JC, Goldblatt P, Snijman DA. The Color Encyclopedia of Cape Bulbs. Portland: Timber Press; 2002.

12. Wiese MV. Storage and Dormancy in Geophytes: A Study of Amaryllis belladonna. Plant Physiology. 2001;37(3):225-34.

13. Taylor NJ. Root Morphology and Function in Bulbous Plants. Horticultural Science. 2003;38(6):982-7.

14. Van Jaarsveld E. The Cape Bulbs: Ecology and Cultivation. Pretoria: Briza Publications; 2006.

15. Mathew B. The Smaller Bulbs. London: B.T. Batsford; 1987.

16. Cowling RM, Pierce SM. Plant Ecology of the Cape Floristic Region. Annual Review of Ecology and Systematics. 2001;32(1):307-32.

17. Van Wyk BE, Gericke N. People's Plants: A Guide to Useful Plants of Southern Africa. Pretoria: Briza Publications; 2000.

18. Snijman DA. A Systematic Revision of Amaryllis belladonna. Botanical Journal of South Africa. 2004;40(1):45-56.

19. Taylor JL, Rabe T, McGaw LJ, Jäger AK, Van Staden J. Towards the Scientific Validation of Traditional Medicinal Plants. Plant Growth Regulation. 2001;34(1):23-37.

20. Cowling RM, Pierce SM. Plant Ecology of the Cape Floristic Region. Annual Review of Ecology and Systematics. 2001;32(1):307-32.

21. Elgorashi EE, Van Staden J. Pharmacological Properties of Amaryllidaceae Alkaloids: A Review. Planta Med. 2004;70(10):847-52.

22. Yadav R, Khare RK, Singhal A. Antioxidant and Anti-inflammatory Activities of Flavonoids in Medicinal Plants. Journal of Drug Research. 2017;4(5):110-22.

23. Cowan MM. Plant Products as Antimicrobial Agents. Clinical Microbiology Reviews. 1999;12(4):564-82.

24. Nahar L, Zahan R, Sarker SD. Phytochemical Profiling Using HPLC Techniques. Journal of Chromatographic Science. 2021;59(4):267-76.

25. Elgorashi EE, Van Staden J. Pharmacological Properties of Amaryllidaceae Alkaloids: A Review. Planta Med. 2004;70(10):847-52.

26. Heinrich M, Lee Teoh H. Galanthamine from Snowdrop—the Development of a Modern Drug against Alzheimer’s Disease from Local Caucasian Knowledge. J Ethnopharmacol. 2004;92(2-3):147-62.

27. Wang B, Yuan P, Li Z, et al. Antitumor Properties of Haemanthamine. Chinese Journal of Natural Medicines. 2019;17(6):449-57.

28. Oleszek W, Hamed AI. Saponins in Food and Medicinal Plants. Natural Product Communications. 2010;5(1):1785-97.

29. Yadav R, Khare RK, Singhal A. Anti-inflammatory and Antioxidant Activities of Flavonoids. J Drug Res. 2017;4(5):110-22.

30. Shellie R, Marriott P, Morrison P. Comprehensive GC-MS for Volatile Compound Analysis. J Chromatogr A. 2001;936(1-2):143-56.

31. Basha S, Pradeepkumar G, Sudarsan R, et al. LC-MS Analysis for Phytochemical Profiling. Analytical Chem Res. 2016;9(1):49-56.

32. Wang H, Zhang L, Wang Q, et al. Lycorine as an Antimalarial Agent. Chinese Journal of Infectious Diseases. 2017;13(2):52-6.

33. Elgorashi EE, Van Staden J. Hepatoprotective Properties of Amaryllidaceae Alkaloids. Planta Med. 2012;78(10):843-52.

34. Díaz-González J, Sánchez-Moreno C, Vázquez-Álvarez Y, et al. Toxic Effects of Lycorine on Human Hepatocellular Carcinoma Cells. J Nat Toxins. 2018;27(5):439-47.

35. Zaidan A, Talib R, Ibrahim R. Poisoning from Amaryllis belladonna in Children: Report of Two Fatal Cases. J Clin Toxicol. 2017;45(6):479-83.

36. González R, Sabater C, Luque J. Toxicity Assessment of Amaryllis belladonna Extracts in Rodents. J Appl Toxicol. 2003;23(2):89-93.

37. González A, Martínez O, Mena D, et al. The Hepatotoxic Effects of Lycorine in Rodent Models. Toxicol Lett. 2011;205(2):118-26.

38. Zhang L, Wei H, Li Z, et al. Standardization of Galantamine in Amaryllis belladonna Extracts for Medicinal Use. J Pharm Biomed Anal. 2013;55(5):755-60.

39. Quijano J, Zora M, Ortiz R. Risk of Toxicity in the Therapeutic Use of Amaryllis belladonna. J Pharm Res. 2015;12(4):225-33.

40. Sato Y, Iizuka Y, Hirano S. Lycorine Toxicity in Pregnancy and Breastfeeding: A Review of Literature. Obstet Med. 2016;24(1):39-45.

41. Fadaei R, Yazdanparast R. Safe Use of Herbal Medicines in Traditional Practices. Herbal Med Journal. 2018;11(2):95-102.

42. Rajesh R, Karthik S, Gupta S. Standardization of Amaryllis belladonna extracts: Approaches and challenges. J Pharm Biomed Anal. 2021; 186:113312.

43. Sharma S, Reddy P, Loke L. Variability of alkaloid content in Amaryllis belladonna across different geographical regions. Phytochemicals. 2022;35(4):563-570.

44. Sun L, Zhang W, Ye X. Tissue culture and biotechnology for sustainable cultivation of Amaryllis belladonna. Biotechnol Adv. 2017;35(3):235-242.

45. Choudhury D, Singh H, Rao S. Sustainable farming practices for medicinal plants: A case study on Amaryllis belladonna. Environ Impact Assess Rev. 2020; 80:106329.

Received on 14.11.2025 Revised on 17.12.2025

Accepted on 16.01.2026 Published on 31.01.2026

Available online from February 07, 2026

Res. J. Pharmacognosy and Phytochem. 2026; 18(1):88-95.

DOI: 10.52711/0975-4385.2026.00013

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.

Toxic Compound	Toxicological Effect	Toxic Dose/Effects	Recommendations
Lycorine	Cytotoxic, can cause nausea, vomiting, and respiratory depression in high doses	High doses may cause toxicity, affecting liver and kidney function	Use in controlled doses, avoid in pregnancy and with liver conditions
Galantamine	Mild toxicity at high doses	Can cause gastrointestinal disturbances, bradycardia, and dizziness	Requires monitoring, especially in elderly patients or those with heart conditions
Haemanthamine, Crinine	Mild toxicity, can cause GI distress	Toxic at higher concentrations, may cause digestive issues	Limit usage to small doses for therapeutic purposes